Incidence and Predictive Factors of Intestinal Injury in Patients Undergoing Heart Valve Replacements
Official Title is Required by the WHO and ICMJE
1 other identifier
observational
1,000
1 country
1
Brief Summary
The purpose of this study is to investigate the incidence and predictive factors related to intestinal injury in patients undergoing heart valve replacement through a multicenter study in China.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 16, 2012
CompletedFirst Posted
Study publicly available on registry
January 24, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2012
CompletedJanuary 24, 2012
January 1, 2012
1 year
January 16, 2012
January 19, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
score of gut dysfunction
At different time points, gut dysfunction is graded according to previous criterion.
eight months
Secondary Outcomes (2)
The duration of cardiopulmonary bypass
Eight months
The duration for aortic artery clamping
eight months
Study Arms (1)
patients with cardiac surgery
Eligibility Criteria
Patients undergoing heart valve replacements under cardiopulmonary bypass
You may qualify if:
- Patients undergoing heart valve replacements under cardiopulmonary bypass
You may not qualify if:
- Patients who die during or after operation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cai Lilead
Study Sites (1)
Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510080, China
Biospecimen
Blood samples are retained for the detections of some biomarkers and gene polymorphism.
Study Officials
- PRINCIPAL INVESTIGATOR
Ke Xuan Liu, MD, Ph.D
First Affiliated Hospital, Sun Yat-Sen University
Central Study Contacts
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Vice head of Dept. of Anesthesiology
Study Record Dates
First Submitted
January 16, 2012
First Posted
January 24, 2012
Study Start
October 1, 2011
Primary Completion
October 1, 2012
Study Completion
November 1, 2012
Last Updated
January 24, 2012
Record last verified: 2012-01